EN | TR
E-ISSN: 2651-2661 ISSN: 2651-2653
Comparison of osteoporosis frequency in female patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis
PDF
Cite
Share
Request
Original Article
VOLUME: 16 ISSUE: 2
P: 51-56
July 2024

Comparison of osteoporosis frequency in female patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis

J Turk Soc Rheumatol 2024;16(2):51-56
DOI: 10.4274/raed.galenos.2024.70893
Bekir Torun
Şükran Erten
No information available.
No information available
Received Date: 03.04.2024
Accepted Date: 27.06.2024
Online Date: 22.07.2024
Publish Date: 22.07.2024
PDF
Cite
Share
Request

Abstract

Objective

The aim of this study is to determine of the frequency of osteoporosis in patient with non-radiographic axial spondyloarthritis (SpA) and ankylosing spondilitis. The correlation between frequency of osteoporosis and disease activity and severity will be investigated in these patient.

Methods

The study retrospectively inculede 53 patients with non-radiographic axial SpA, 43 patients with ankylosing spondilitis diagnosed according modified new york criteria and 61 healthy volunteers, who her admitted to the Ankara Atatürk Researc hospital rheumatology deparment between november 2013 and may 2015.

Results

In the patient group with Ankylosing spondilitis, osteoporosis was detected in 7 patient (16.3%) osteopenia was detected in 16 patient (37.2%) and 20 patient is normal (46.5%). In the non-radiographic axial SpA group 4 patient had osteporosis (7.5%), 18 patient (34.0%) had osteopenia and 31 patient (58.5%) had normal. Osteporosis was detected in 4 (6.6%) of the total 61 patient in the control group, osteopenia was detected in 28 (45.9%), while bone mineral densitometry was normal in 29 patient (47.5%).

Conclusion

In our study frequency of osteoporosis in both ankylosing spondilitis and non-radiographic axial SpA was found to be close and no statistically significant difference was observed. We can recommend that who are followed up with non-radiographic axial SpA be screened for osteoporosis during the follow-up periods. Randomized, prospective studies with a large number of patients will increase our knowledge on this subject.

References

1
Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377:2127-37.
2
Onen F, Solmaz D, Cetin P, et al. Prevalence of Inflammatory Back Pain and Axial Spondyloarthritis Among University Employees in Izmir, Turkey. J Rheumatol. 2015;42:1647-51.
3
Mei J, Hu H, Ding H, et al. Investigating the causal relationship between ankylosing spondylitis and osteoporosis in the European population: a bidirectional Mendelian randomization study. Front Immunol. 2023;14:1163258.
4
Tuzun S, Eskiyurt N, Akarirmak U, et al. Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos Int. 2012;23:949-55.
5
van der Weijden MA, Claushuis TA, Nazari T, Lems WF, Dijkmans BA, van der Horst-Bruinsma IE. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review. Clin Rheumatol. 2012;31:1529-35.
6
Sharif K, Tsur AM, Ben-Shabat N, Watad A, Cohen AD, Amital H. The risk of osteoporosis in patients with ankylosing spondylitis-A large retrospective matched cohort study. Med Clin (Barc). 2023;160:373-378. English, Spanish.
7
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361-8.
8
Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73-8.
9
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286-91.
10
Poole KE, Compston JE. Osteoporosis and its management. BMJ. 2006;333:1251-6.
11
Gowen M, Mundy G. Actions of recombinant interleukin 1, interleukin 2, and interferon-γ on bone resorbtion in vitro. J Immunol. 1986;136:2478-82.
12
Heath J, Saklatvala J, Meikle M, Atkinson S, Reynolds J. Pig interleukin 1 (catabolin) is a potent stimulator of bone resorbtion in vitro. Calcif Tissue Int. 1985;7:95-7.
13
Bessant R, Keat A. How should clinicians manage osteoporosis in Ankylosing Spondylitis. J Rheumatol. 2002;29:1511-9.
14
Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009;44:772-6.
15
Malochet-Guinamand S, Pereira B, Tatar Z, et al. Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures. BMC Musculoskelet Disord. 2017;18:357.
16
Ferjani HL, Boudriga O, Nessib DB, Kaffel D, Maatallah K, Hamdi W. Probability of the 10-year Risk of Hip and Major Osteoporotic Fracture in Non-radiographic Axial Spondyloarthritis. Curr Rheumatol Rev. 2024;20:82-7.
17
Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R. Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol. 2011;30:691-5.
18
Bodur H, Ataman S, Buğdayci DS, et al; Türkiye Romatizma Araştirma ve Savaş Derneği [TRASD] (Turkish League Against Rheumatism) Ankylosing Spondylitis [AS] Study Group. Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP. Rheumatol Int. 2012;32:169-176.
19
Klingberg E, Lorentzon M, Mellström D, et al. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14: R108.
20
Hayal G, Nilgün Ü, Veli EB, et al. Assessment of the Relationship Between Bone Mineral Density and Disease Activity in Ankylosing Spondylitis Patients with Osteopenia. Turk J Osteoporos. 2013;19:0-0.